Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Single Arm Trial With Sacituzumab Govitecan as Neoadjuvant Therapy in Pts With Non-Urothelial Muscle Invasive Bladder Cancer

NCT05581589 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05581589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05581589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Single Arm Trial With Sacituzumab Govitecan as Neoadjuvant Therapy in Pts With Non-Urothelial Muscle Invasive Bladder Cancer
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Terminated
Start date
June 15, 2023
Completion date
March 6, 2026
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle invasive bladder carcinoma, stage ii bladder cancer ajcc v8, stage iiia bladder cancer ajcc v8